FDA Launches “Remove the Risk” Campaign for Safe Disposal of Unused Opioids
The U.S. Food and Drug Administration is launching on April 25, 2019, its “Remove the Risk” campaign, aimed at promoting the safe disposal of unused opioids.
Pain Management Information Center
CDC Provides Clarification of Opioid Prescribing Guideline
Misapplication of the guideline can put patient health and safety at risk.
FDA Approves First Generic Nasal Spray Against Opioid Overdose
The first generic naloxone nasal spray to treat opioid overdose has received approval from the US Food and Drug Administration.
Opioid Prescription of 4 to 7 Days May Be Sufficient for Acute Pain Management
An initial prescription of opioids for 4 to 7 days for the management of acute pain in the primary care setting was found to be sufficient.
Psychological Treatments Show Efficacy in Primary Headache Disorder
Researchers found data to support psychological treatments to reduce the number of headaches and the headache index.
Opioid Prescriptions Dropped for New Users From 2012 to 2017
Many providers stopped initiating opioid therapy from July 2012 to December 2017.
HHS Task Force Issues Draft Report on Best Practices for Pain Management
In a draft report issued December 28, 2018 by the US Department of Health and Human Services-sponsored Pain Management Best Practices Inter-Agency Task Force, recommendations for a multidisciplinary approach to pain management were formulated.
Mindfulness-Based Cognitive Therapy May Be Efficacious for Chronic Low Back Pain
Mindfulness-based cognitive therapy may represent a feasible and efficacious treatment for chronic low back pain.
Non-Invasive Device Gets FDA Clearance for Migraine Treatment, Prevention in Younger Patients
The FDA has granted marketing clearance for eNeura’s single-pulse transcranial magnetic stimulation (sTMS) device for use in patients ≥12 years for the acute and prophylactic treatment of migraine.
Converting Naloxone to OTC Expected to Increase Sales
Demand for naloxone is inelastic, with 1% increase in price resulting in 0.27% drop in sales
High-Flow Oxygen for Cluster Headache Effective With Few Complications
High-flow oxygen was found to be effective for cluster headaches, with less complications than seen with triptans.
Higher Optimism Tied to Lower Odds of Pain After Deployment
Soldiers with low optimism had increased odds of reporting new back pain, joint pain, headaches.
Slump Stretching May Be Beneficial in Low Back Pain
Slump stretching may be beneficial to individuals with low back pain — based on very low to moderate quality evidence — according to a meta-analysis published in Pain Medicine. Slump stretching is achieved when sitting in a slouched position (ie, with thoracic and lumbar flexion and a posterior pelvic tilt) and actively flexing one’s cervical spine as far…
Opioid-Induced Constipation: Insights Into Diagnosis and Effective Treatment
Conventional approaches to treatment of opioid-induced constipation include the use of treatment modalities that address non-opioid-related constipation as well as new medications that target the OIC mechanism of action.
Evidence of Therapeutic Efficacy Substantial for Cannabis Use
Substantial, conclusive evidence of therapeutic efficacy found for 85.5% of qualifying conditions.
Compounded Topical Pain Creams No Better Than Placebo
At 1 month, no significant difference seen in positive outcomes for treatment vs control.
Direct-to-Doctor Payments May Increase Opioid Prescribing
Prescribers receiving opioid-specific payments prescribed 8784 more opioid daily doses per year.
Buprenorphine-Naloxone Found to Be More Cost-Effective Than Extended-Release Naltrexone
Buprenorphine-naloxone may be more cost-effective than extended-release naltrexone as first-line treatment for opioid use disorder.
As Shutdown Drags On, Opioid Crisis Looms Large
As the government shutdown drags in to its second month, physicians who treat opioid use disorders are being backed against a wall.
Meta-Analysis of Opioid Treatment for Chronic Noncancer Pain
Opioids may only provide limited benefits for the management of chronic noncancer pain and may be associated with a greater risk for vomiting.
Want to read more?
Please login or register first to view this content.
Next post in News
